PHARMACEUTICAL

CARE PLAN
ALLONDRA PADUA ZULUETA, RPh
PRE-LAB DISCUSSION
INDICATION
GOAL OF THERAPY
 1. Goals of therapy are established for each
indication for drug therapy.

2. Desired goals of therapy are described in terms of

the observable or measurable clinical and/or
laboratory parameters to be used to evaluate
MEASUREMENT effectiveness and safety of drug therapy

CRITERIA 3. Goals of therapy are mutually negotiated with the

patient and health care providers when appropriate.

4. Goals of therapy are realistic in relation to the

patient's present and potential capabilities.

5. Goals of therapy include a timeframe for

achievement.
 1. Cure a disease

2. Reduce or eliminate signs and/or

symptoms

The goals of drug 3. Slow or halt the progression of a

disease
therapy are to: 4. Prevent a disease

5. Normalize laboratory values

6. Assist in the diagnostic process

 For a patient who suffers from
allergic rhinitis and presents with
nasal congestion, runny nose, and
eye itching, but no cough or loss of
taste, the patient-specific goals of
therapy might include the relief of
EXAMPLE the patient's complaints of nasal
congestion, runny nose, and eye
itching in a timeframe of 48 hours.
INTERVENTION
 If your patient is not realizing the full
effectiveness from her prescribed
antihistamine to manage seasonal
Interventions to allergic rhinitis because the dose is too
Resolve Drug low, the dosage regimen must be
increased before there is any realistic
Therapy Problems hope of achieving a positive outcome.

Similarly, if your patient is experiencing

dose-related side effects from her
antihistamine, the dosage regimen must
be modified in order for her to receive
appropriately indicated drug therapy
that is both effective and safe.
 Interventions to achieve the goals of
therapy can include the drug reg imen(s)
the patient should receive, changes in
Interventions to drug therapy that are required,
Achieve Goals of patient-specific education or information,
referrals to specialists, instructions on
Therapy how to properly use prescription drug
products, nonprescription drug products,
and how to use other remedies,
products, and devices.
FOLLOW-UP
EVALUATION
 1. The clinical and laboratory
parameters to evaluate effectiveness are
established, and a timeframe for
collecting the relevant information is
Measurement selected.

criteria 2. The clinical and laboratory

parameters that reflect the safety of the
patient's medications are selected, and a
timeframe for collecting the relevant
information is determined.

3. A schedule for the follow-up

evaluation is established with the patient
 1. The clinical and laboratory
Measurement parameters to evaluate effectiveness are
established, and a timeframe for
criteria: collecting the relevant information is
selected.
Evaluate the
2. The clinical and laboratory
effectiveness of parameters that reflect the safety of the
patient's medications are selected, and a
drug therapies and timeframe for collecting the relevant
assess any adverse information is determined.

3. A schedule for the follow-up

event evaluation is established with the patient
 1. The patient's outcomes from drug
Measurement therapies and other interventions are
documented.
criteria:
2. The effectiveness of drug therapies is
Evaluate the evaluated, and the patient's status is
outcomes, progress, determined by comparing the outcomes
within the expected timeframe to
achievement of goal achieve the goals of therapy.

therapy, and 3. The safety of the drug therapy is

evaluated.
determine safety
4. Patient compliance is evaluated.
and effectiveness
 5. The care plan is revised, as needed.
Measurement 6. Revisions in the care plan are
criteria: documented.

Evaluate the 7. Evaluation is systematic and ongoing

until all goals of therapy are achieved.
outcomes, progress,
8. The patient, family and/or
achievement of goal care-givers, and health care providers
therapy, and are involved in the evaluation process,
when appropriate.
determine safety
and effectiveness
Three basic questions
1. When should the follow-up evaluation be scheduled?

2. How will you determine if positive outcomes have occurred?

3. How will you determine if negative outcomes have occurred?

Questions to conclude the care plan:

- Your next follow-up evaluation should take place in 4-6 weeks.
- When would you like to schedule our next visit?
- How would you prefer to be contacted-by telephone, fax, or e-mail? Is there a
best time to reach you?
DOCUMENTATION
- The care plan document lists the indication and includes a brief summary of the
signs and symptoms, Goals of therapy must be a prominent part of every care
plan. One of the most valued additions that a pharmaceutical care practitioner
makes to the patient's health records is explicitly stated goals of therapy.

NOTE:

- Students may want to record two or three therapeutic alternatives which were
considered for each indication to ensure that the most rational options been
considered.
Thank you!